The economic burden of prostate cancer – a Swedish prevalence-based register study

Hao, Shuang; Östensson, Ellinor; Eklund, Martin; Grönberg, Henrik; Nordström, Tobias; Heintz, Emelie; Clements, Mark

doi:10.1186/s12913-020-05265-8

BMC Health Services Research

Table 4 Costs of managing prostate cancer by treatment pathway, 2016 (€)

From: The economic burden of prostate cancer – a Swedish prevalence-based register study

Module/Procedure	Unit cost (€) base/alternative	Resource use base/alternative	Cost/patient (€) base/alternative	Source/Remarks
Diagnosis
PSA test at primary care
GP visit	152	0.2	30	[29,30,31,32, 72]
PSA test analysis	4	1	4	[33]
Total costs/patient			34
Biopsy at outpatient care: w/o MRI
Specialist and nurse consultation	147	1	147	[73]
Ultrasound	151 / 212	1	151 / 212	[74] / [73]
Biopsy	304	1	304	[33]
Pathology	516	1	516	[73]
Nurse consultation	40	1	40	[73]
Total costs/patient			1159 / 1220
Biopsy at outpatient care: with MRI
Specialist and nurse consultation	147	1	147	[73]
Ultrasound	151 / 212	1	151 / 212	[74] / [73]
MRI	354 / 569	1	354 / 569	[73] / [74]
Biopsy	304	1	304	[73]
Pathology	516	1	516	[33]
Nurse consultation	40	1	40	[73]
Total costs/patient			1513 / 1789
Treatment
Active surveillance at outpatient care: w/o MRI
Specialist and nurse consultation	147	1	147	[73]
PSA test sampling	36	1	36	[29]
PSA test analysis	4	3 / 4	11 / 15	[33]
Ultrasound	151	0.33 / 0.5	50 / 76	[74]
Biopsy	304	0.33 / 0.5	100 / 152	[73]
Pathology	516	0.33 / 0.5	170 / 258	[33]
Total costs/patient			587/ 792	*Annual cost*
Active surveillance at outpatient care: with MRI
Specialist and nurse consultation	147	1	147	[73]
PSA test sampling	36	3 / 4	108 / 144	[29]
PSA test analysis	4	3 / 4	11 / 15	[33]
Ultrasound	151	0.33 / 0.5	50 / 76	[74]
MRI	354 / 569	0.33 / 0.5	117 / 285	[73] / [74]
Biopsy	304	0.33 / 0.5	100 / 152	[73]
Pathology	516	0.33 / 0.5	170 / 258	[33]
Total costs/patient			704 / 1077	*Annual cost*
Radical prostatectomy at inpatient care: open surgery
Open surgery	7422	1	7422	[12]
Specialist and nurse consultation	147	1 / 2	147 / 295	[73]
RT	672	0.25	168	[12]
Total costs/patient			7738 / 7885
Radical prostatectomy at inpatient care: robot-assistant
Robot assisted surgery	9941 / 12,328	1	9941 / 12,328	[12]
Specialist and nurse consultation	147	1 / 2	147 / 295	[73]
RT	672	0.25	168	[12]
Total costs/patient			10,257 / 12,791
Radiation therapy at outpatient care
Oncologist - new visit	397	1	397	[32]
Oncologist - further visit	171	1	171	[32]
Nurse consultation	40	20	808	[73]
RT	672	20	13,440	[12] [75]
Hormone therapy-annual	6867	0.20	1373
Total costs/patient			16,189
Metastatic: Chemo + Hormone therapy
Annual cost/patient	7283	1	7283	Results of study
Total costs/patient			7283	*Annual costs*
Metastatic: Hormone therapy
Annual cost/patient	6867	1	6867	Results of study
Total costs/patient			2136	*Annual costs*
Post treatment follow-up
Post treatment follow-up: Low/intermediate risk
Specialist and nurse consultation	147	1	147	[73]
Specialist consultation - Tele follow-up	15	11	162	[73]
PSA test sampling	36	12	432	[29]
PSA test analysis	4	12	46	[33]
Total costs/patient			788
Post treatment follow-up: High risk
Specialist and nurse consultation	147	1	147	[73]
Specialist consultation - Tele follow-up	15	14	206	[73]
PSA test sampling	36	15	541	[29]
PSA test analysis	4	15	57	[33]
Total costs/patient			952

GP General Practitioner, MRI Magnetic Resonance Imaging, PSA Prostate-specific Antigen, RT Radiation Therapy

Back to article page

ISSN: 1472-6963

Contact us

General enquiries: journalsubmissions@springernature.com